<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2016-4-70-74</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-449</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РАЗНОЕ</subject></subj-group></article-categories><title-group><article-title>ГЕНДЕРНЫЕ ОСОБЕННОСТИ СУБФРАКЦИОННОГО РАСПРЕДЕЛЕНИЯ ЛИПОПРОТЕИНОВ ПЛАЗМЫ КРОВИ</article-title><trans-title-group xml:lang="en"><trans-title>GENDER SPECIFICS OF SUBFRACTIONAL PLASMA LIPOPROTEIDS DISTRIBUTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Озерова</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ozerova</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат биологических наук, ведущий научный сотрудник отдела изучения биохимических маркеров риска ХНИЗ.</p><p>Тел.: 8 (499) 553-68-51; моб. тел.: 8 (916) 089-19-49, e-mail: iozerova@gnicpm.ru</p></bio><email xlink:type="simple">iozerova@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Метельская</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Metelskaya</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор биологических наук, профессор, руководитель отдела изучения биохимических маркеров риска ХНИЗ</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаврилова</surname><given-names>Н. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Gavrilova</surname><given-names>N. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, старший научный сотрудник отдела клинической кардиологии и молекулярной генетики</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научно-исследовательский центр профилактической медицины, Минздрав России, Москва</institution></aff><aff xml:lang="en"><institution>National Research Center for Preventive Medicine of the Ministry of Health, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>08</month><year>2016</year></pub-date><volume>15</volume><issue>4</issue><fpage>70</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Озерова И.Н., Метельская В.А., Гаврилова Н.Е., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Озерова И.Н., Метельская В.А., Гаврилова Н.Е.</copyright-holder><copyright-holder xml:lang="en">Ozerova I.N., Metelskaya V.A., Gavrilova N.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/449">https://cardiovascular.elpub.ru/jour/article/view/449</self-uri><abstract><sec><title>Цель</title><p>Цель. Выяснить, имеются ли особенности  субфракционного  распределения   липопротеинов  плазмы  крови  у мужчин и  женщин в зависимости от наличия коронарного атеросклероза.</p></sec><sec><title>Материал  и методы</title><p>Материал  и методы. В исследование включены 310 пациентов (203 мужчины и 107 женщин), которым была выполнена коронароангиография; поражение коронарных артерий оценивали по шкале Gensini Score (GS). Субфракционный спектр липопротеинов плазмы крови определяли  методом  электрофореза в 3% полиакриламидном  геле  при  использовании  Липопринт системы  (Quantimetrix Lipoprint System, США).</p></sec><sec><title>Результаты</title><p>Результаты. В группе пациентов без поражения коронарных артерий (GS =0) гендерные различия в концентрации липидов, аполипопротеинов и показателей  утилизации глюкозы отсутствовали. Среди пациентов с коронарным атеросклерозом (GS &gt;0) мужчины имели более низкие концентрации холестерина липопротеинов низкой и высокой плотности (ХС ЛНП и ХС ЛВП), а также апо АI и апо В. Мужчины как при GS =0, так и c GS &gt;0 отличались от женщин более  низким  показателем   липопротеинов  промежуточной плотности (ЛПП) — ЛПП В и ЛПП А, и более высокой долей ЛНП 2 и мелких плотных частиц ЛНП 3, при этом средний размер  частиц ЛНП был  меньше.  Различий  в  распределении субфракций  ЛВП у мужчин и женщин не обнаружено, но у мужчин только при коронарном атеросклерозе были выявлены более низкие концентрации ХС в составе всех субфракций ЛВП.</p></sec><sec><title>Заключение</title><p>Заключение. Обнаружены гендерные  различия  в субфракционном спектре ЛПП и ЛНП: у мужчин независимо  от наличия коронарного атеросклероза при одном и том же и даже более низком уровне ХС ЛНП имело место накопление более атерогенных мелких плотных частиц ЛНП. Гендерные различия в доле субфракций ЛВП не обнаружено, однако y мужчин концентрация ХС в каждой субфракции при коронарном атеросклерозе оказалась  ниже, чем у женщин.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To find out, whether there is specifics of subfractional distribution of plasma  lipoproteides  in men  and  women depending  on coronary atherosclerosis.</p></sec><sec><title>Material and methods</title><p>Material and methods. Totally 310 patients included (203 males, 107 females), underwent coronary arteriography; lesion of artery was assessed with Gensini Score  (GS). Subfractional spectrum  of plasma lipoproteides  was studied via electrophoresis in 3% polyacrylamid gel with Lipoprint system (Quantimetrix Lipoprint System, USA).</p></sec><sec><title>Results</title><p>Results. In the  group  without lesion (GS =0) gender  differences  of lipids, apolipoproteides and glucose utilization parameters were absent. Among coronary  atherosclerosis patients  (GS &gt;0)  males  had  lower concentrations of low and high density cholesterol (LDL, HDL), as Apo A1 and Apo B. Males with GS =0, as with GS &gt;0 differed from females by lower lipoproteides of intermediate density (LID) — LID B and LID A, and higher part of LDL 2 and small dense  particles LDL 3, but mean size of LDL particles was smaller. There were no differences in HDL subfractions distribution  among  men  and  women,  but  in men  only if  coronary atherosclerosis, there were lower cholesterol concentrations found in all HDL subfractions.</p></sec><sec><title>Conclusion</title><p>Conclusion. Gender differences are revealed in subfractional spectrum of LID and LDL: in men regardless coronary atherosclerosis with the same and even lower level of LDL cholesterol there was accumulation of more atherogenic  small dense  LDL particles. Gender differences in the part of HDL subfractions were not found, but in men concentration of cholesterol in each of subfractions, with coronary lesion, was lower than in women. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гендерные  различия</kwd><kwd>субфракционный спектр липопротеинов</kwd><kwd>Липопринт система</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gender differences</kwd><kwd>subfractional spectrum of lipoproteides</kwd><kwd>Lipoprint system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Oganov RG, Maslennikova GYa. Specifics of cardiovascular pathology. Cardiovascular Therapy and Prevention 2012; 11(4): 101-4. Russian (Оганов Р. Г., Масленникова Г. Я. Гендерные различия кардиоваскулярной патологии. Кардиоваскулярная терапия и профилактика 2012; 11(4): 101-4).</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Maslennikova GYa. Specifics of cardiovascular pathology. Cardiovascular Therapy and Prevention 2012; 11(4): 101-4. Russian (Оганов Р. Г., Масленникова Г. Я. Гендерные различия кардиоваскулярной патологии. Кардиоваскулярная терапия и профилактика 2012; 11(4): 101-4).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, et al. Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Disease Markers 2013; 5(2): 85-96.</mixed-citation><mixed-citation xml:lang="en">Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, et al. Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations. Disease Markers 2013; 5(2): 85-96.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cifkova R, Krajcoviechova A. Dyslipidemia and cardiovascular disease in women. Curr Cardiol Rep 2015; 17(7): 609-18.</mixed-citation><mixed-citation xml:lang="en">Cifkova R, Krajcoviechova A. Dyslipidemia and cardiovascular disease in women. Curr Cardiol Rep 2015; 17(7): 609-18.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002 ;43: 1363-79.</mixed-citation><mixed-citation xml:lang="en">Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002 ;43: 1363-79.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Koba S, Yokota Y, Hirano T, et al. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb 2008; 15(5): 250-60.</mixed-citation><mixed-citation xml:lang="en">Koba S, Yokota Y, Hirano T, et al. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb 2008; 15(5): 250-60.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Annema W, von Eckard A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77: 2432-48.</mixed-citation><mixed-citation xml:lang="en">Annema W, von Eckard A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77: 2432-48.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Srisawasdi P, Vanavanan S, Rochanawutanon M, et al. Heterogeneous properties of intermediateand low-density lipoprotein subpopulations. Clin Biochem 2013; 46(15): 1509-15.</mixed-citation><mixed-citation xml:lang="en">Srisawasdi P, Vanavanan S, Rochanawutanon M, et al. Heterogeneous properties of intermediateand low-density lipoprotein subpopulations. Clin Biochem 2013; 46(15): 1509-15.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">El Khoudary SR, Brooks MM, Thurston RC, et al. Lipoprotein subclasses and endogenous sex hormones in women at midlife. J Lipid Res 2014; 55(7): 1498-504.</mixed-citation><mixed-citation xml:lang="en">El Khoudary SR, Brooks MM, Thurston RC, et al. Lipoprotein subclasses and endogenous sex hormones in women at midlife. J Lipid Res 2014; 55(7): 1498-504.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vaidya D, Dobs A, Gapstur SM, et al. The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis. Metabolism 2008; 57(6): 782-90.</mixed-citation><mixed-citation xml:lang="en">Vaidya D, Dobs A, Gapstur SM, et al. The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis. Metabolism 2008; 57(6): 782-90.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Anagnostis P, Stevenson JC, Crook D, et al. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas 2015; 81(1): 62-8.</mixed-citation><mixed-citation xml:lang="en">Anagnostis P, Stevenson JC, Crook D, et al. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas 2015; 81(1): 62-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hoefner DM, Hodel SD, O'Brein JF, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001; 47(2): 266-74.</mixed-citation><mixed-citation xml:lang="en">Hoefner DM, Hodel SD, O'Brein JF, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001; 47(2): 266-74.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gavrilova NE, Metelskaya VA, Perova NV, et al. Selection for the quantitative evaluation method of coronary arteries based upon comparative analysis of angiographic scales. Russ J Cardiol 2014; 6(110): 24-9. Russian (Гаврилова Н. Е., Метельская В. А., Перова Н. В. и др. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа анги-ографических шкал. Российский кардиологический журнал 2014, 6(110): 24-9).</mixed-citation><mixed-citation xml:lang="en">Gavrilova NE, Metelskaya VA, Perova NV, et al. Selection for the quantitative evaluation method of coronary arteries based upon comparative analysis of angiographic scales. Russ J Cardiol 2014; 6(110): 24-9. Russian (Гаврилова Н. Е., Метельская В. А., Перова Н. В. и др. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа анги-ографических шкал. Российский кардиологический журнал 2014, 6(110): 24-9).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mombelli G, Bosisio R, Calabresi L, et al. Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention. J Clin Lipidol 2015; 9(2): 226-33.</mixed-citation><mixed-citation xml:lang="en">Mombelli G, Bosisio R, Calabresi L, et al. Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention. J Clin Lipidol 2015; 9(2): 226-33.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Decewicz DJ, Neatrour DM, Burke A, et al. Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy. Lipids Health Dis 2009; 8: 26-39.</mixed-citation><mixed-citation xml:lang="en">Decewicz DJ, Neatrour DM, Burke A, et al. Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy. Lipids Health Dis 2009; 8: 26-39.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gomaraschi M, Adorni MP, Banach M, et al. Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function. Handb Exp Pharmacol 2015; 224: 593-615.</mixed-citation><mixed-citation xml:lang="en">Gomaraschi M, Adorni MP, Banach M, et al. Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function. Handb Exp Pharmacol 2015; 224: 593-615.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
